Parkside Financial Bank & Trust Amphastar Pharmaceuticals, Inc. Transaction History
Parkside Financial Bank & Trust
- $976 Million
- Q3 2025
A detailed history of Parkside Financial Bank & Trust transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 173 shares of AMPH stock, worth $4,508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173
Previous 136
27.21%
Holding current value
$4,508
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding AMPH
# of Institutions
263Shares Held
33.5MCall Options Held
73.4KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$68.6 Million0.0% of portfolio
-
Td Asset Management Inc1.93MShares$50.3 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.76MShares$45.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.5MShares$39.1 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.28B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...